BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 1378139)

  • 41. Atenolol with and without nifedipine in the treatment of angina pectoris. Preliminary report.
    Sandberg M; Foale RA
    Drugs; 1988; 35 Suppl 4():51-5. PubMed ID: 3132360
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A comparison of epanolol and nifedipine in stable angina patients: results of a multicentre trial.
    Blake P; Berry SC; Readman A; Ratcliffe M; Godley M
    Cardiology; 1991; 79(4):249-55. PubMed ID: 1685942
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Total Ischaemic Burden European Trial (TIBET). Effects of atenolol, nifedipine SR and their combination on the exercise test and the total ischaemic burden in 608 patients with stable angina. The TIBET Study Group.
    Fox KM; Mulcahy D; Findlay I; Ford I; Dargie HJ
    Eur Heart J; 1996 Jan; 17(1):96-103. PubMed ID: 8682138
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Use of carvedilol compared to nifedipine in the treatment of mild and moderate essential arterial hypertension].
    Plavnik FL; Freitas AF; Portela JE; Dantas M; Spritzer T; Kohlmann NE; Spritzer N; Furtado MR; Kohlmann O
    Arq Bras Cardiol; 1994 Nov; 63(5):405-8. PubMed ID: 7611920
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy of nisoldipine combined with beta-adrenergic-blocking drugs in the treatment of chronic stable angina.
    O'Keefe JC; Creamer JE; Banim SO
    Clin Cardiol; 1987 Jun; 10(6):345-50. PubMed ID: 2885117
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antianginal efficacy and improved exercise performance with timolol. Twice-daily beta blockade in ischemic heart disease.
    Harris FJ; Low RI; Paumer L; Amsterdam EA; Mason DT
    Am J Cardiol; 1983 Jan; 51(1):13-8. PubMed ID: 6129794
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A comparative study of carvedilol, slow-release nifedipine, and atenolol in the management of essential hypertension.
    Hall S; Prescott RI; Hallman RJ; Dixon S; Harvey RE; Ball SG
    J Cardiovasc Pharmacol; 1991; 18 Suppl 4():S35-8. PubMed ID: 1721977
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of the antihypertensive effects of carvedilol and metoprolol on resting and exercise blood pressure.
    Franz IW; Agrawal B; Wiewel D; Ketelhut R
    Clin Investig; 1992; 70 Suppl 1():S53-7. PubMed ID: 1350485
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Acute hemodynamic effects of carvedilol in comparison with propranolol in patients with coronary heart disease.
    Wendt T
    Clin Investig; 1992; 70 Suppl 1():S93-7. PubMed ID: 1350491
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Additional antianginal and anti-ischemic efficacy of mibefradil in patients pretreated with a beta blocker for chronic stable angina pectoris.
    Alpert JS; Kobrin I; DeQuattro V; Friedman R; Shepherd A; Fenster PE; Thadani U
    Am J Cardiol; 1997 Apr; 79(8):1025-30. PubMed ID: 9114758
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparative efficacy of nifedipine gastrointestinal therapeutic system versus diltiazem when added to beta blockers in stable angina pectoris.
    Siu SC; Jacoby RM; Phillips RT; Nesto RW
    Am J Cardiol; 1993 Apr; 71(11):887-92. PubMed ID: 8096670
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Double-blind, placebo-controlled study of the long-term efficacy of carvedilol in patients with severe chronic heart failure.
    Krum H; Sackner-Bernstein JD; Goldsmith RL; Kukin ML; Schwartz B; Penn J; Medina N; Yushak M; Horn E; Katz SD
    Circulation; 1995 Sep; 92(6):1499-506. PubMed ID: 7664433
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy of carvedilol in exercise-induced myocardial ischemia.
    Kaski JC; Rodriguez-Plaza L; Brown J; Maseri A
    J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S137-40. PubMed ID: 2454360
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The symptomatic and objective effects of nifedipine in combination with beta-blocker therapy in severe angina pectoris.
    Jenkins RM; Nagle RE
    Postgrad Med J; 1982 Nov; 58(685):697-700. PubMed ID: 6820504
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antihypertensive profile of carvedilol.
    Meyer-Sabellek W; Agrawal B
    Clin Investig; 1992; 70 Suppl 1():S43-52. PubMed ID: 1350484
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Randomized, double-blind comparison of isosorbide-5-mononitrate and delayed-action nifedipine in patients with stable exertional angina. Multicenter Study Group].
    Ueberbacher HJ; Patyna WD; Krepp P; Puespoek J; Neuhaus R; Hilbich K; Bulitta M; Rittinghausen R
    Schweiz Med Wochenschr; 1991 Dec; 121(49):1836-40. PubMed ID: 1754868
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of a new vasodilating beta-blocker, carvedilol, with atenolol in the treatment of mild to moderate essential hypertension.
    Ruilope LM
    Am J Hypertens; 1994 Feb; 7(2):129-36. PubMed ID: 7910028
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antianginal efficacy of carvedilol, a beta-blocking drug with vasodilating activity.
    Rodrigues EA; Lahiri A; Hughes LO; Kohli RS; Whittington JR; Raftery EB
    Am J Cardiol; 1986 Nov; 58(10):916-21. PubMed ID: 2877564
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of the efficacy of atenolol and its combination with slow-release nifedipine in chronic stable angina.
    Meyer TE; Adnams C; Commerford P
    Cardiovasc Drugs Ther; 1993 Dec; 7(6):909-13. PubMed ID: 8011570
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effectiveness of nifedipine GITS in combination with atenolol in chronic stable angina.
    Toal CB; Motro M; Baird MG; Klinke P; Sclarowski S; Zilberman A; Marmor A; Kostuk WJ; Lotan C; Weiss A; Erne P; Palant A; Stolero D; BĂ©langer L; Turpie A
    Can J Cardiol; 1999 Oct; 15(10):1103-9. PubMed ID: 10523477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.